Subject Understanding of the Risks Associated With ZYBAN®, WELLBUTRIN®, WELLBUTRIN SR®, and WELLBUTRIN XL®
Latest Information Update: 25 Jul 2023
At a glance
- Drugs Bupropion (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 13 Feb 2018 Status changed from active, no longer recruiting to completed.
- 26 Dec 2016 New trial record